DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Rad Oncology Homepage

Researchers aim to improve flash therapy for X-ray and proton delivery Cutting cancer treatment times while shrinking the technology

Emory University opens first proton therapy center in Georgia 28th PT center in the U.S.

Elekta Unity MR-linac gains FDA 510(k) clearance Simultaneously delivers radiation dose and visualization of tumors

Dr. Hermann Requardt United Imaging Healthcare appoints senior scientific advisor

Patient denied proton therapy dies, family received $25 million in court Points to the need for greater treatment coverage for certain cancer patients

Microbeam radiation therapy could lead to single session treatments Healthy cells tolerate treatment while tumors lose structure

CMS to unveil mandatory payment model for radiation oncology Part of determining approach that saves more and offers greater quality

European report says radiotherapy 'undervalued' and needing 'greater investment' Equipment shortages, lack of investment, training variations

ViewRay to supply UK's GenesisCare with country's first MRIdian systems Providing soft-tissue imaging in real time and better tumor targeting

Precision cancer care with proton and radiation oncology Some of the latest systems and software entering the market

The first installation of a proton
therapy system in the South of
England has taken place in Reading

First proton therapy system arrives in South of England

by John R. Fischer , Staff Reporter
Ion Beam Applications S.A. has set up the South of England’s first proton therapy system at the Rutherford Cancer Centre at the Thames Valley Science Park in Reading, located just under two hours from London.

Designed by Proton Partners International, the center will be the second in the U.K. to house a proton therapy system, specifically IBA’s ProteusONE solution, following the installation of the first in South Wales in May 2017, and will provide greater access among Londoners and other surrounding areas to an alternative form of treatment to conventional radiation.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



“It’s wonderful to see another of our centers move closer to providing proton beam therapy treatment here in the U.K.,” said Mike Moran, chief executive officer of Proton Partners International, in a statement. “The Rutherford Cancer Centre Thames Valley is particularly exciting. Its close proximity to London and Heathrow allows for it to become a hub for patients in the South of England or those travelling to the U.K. for treatment.”

More than 90,000 cancer patients in the U.K. are treated each year with radical radiotherapy. Of these, 10 percent, according to PPI, would be better off undergoing proton therapy.

Comprised of a 52-ton cyclotron and gantry, the ProteusONE system is designed to administer image-guided intensity-modulated proton therapy, and will enable the Rutherford Cancer Centre Thames Valley to treat 500 patients annually. It also will be joined by Philips Ambient Experience technology, which utilizes colored lights and soothing images to relax and optimize patient experience.

Another item to be implemented is the Veritas SmartVue Natural Window System, the first pre-engineered system that provides beautiful views of the outside before and after treatment to lift the spirits of patients without exposing them to radiation. Its installation at the Reading Centre will be the first for the solution in Europe.

“Once the proton beam therapy facility becomes operational, patients from across the region will have an opportunity to save considerable travel by being treated closer to home than hitherto – benefiting their well-being and also that of their families,” Professor Richard Ellis, director of Health Partnerships at the University of Reading, said in a statement. Today’s events are also highly significant to the University of Reading’s development of, and continuing investment in, the Thames Valley Science Park.”

The first bout of proton therapy was administered to a patient in April at the Rutherford Cancer Centre South Wales in Newport.

PPI is currently building additional Rutherford Cancer Centres in Northumberland and Liverpool as part of its objective to build eight across the U.K. that will be accessible within 90 minutes to 75 percent of the U.K.’s population.

In addition to proton therapy, the centers will offer cancer patients access to radiotherapy, chemotherapy, immunotherapy and well-being services.

The Rutherford Cancer centre Thames Valley is expected to commence radiotherapy treatment this month and the first bouts of proton therapy next year.

Rad Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED